Effect of curcumin supplementation on serum expression of select cytokines and chemokines in a female rat model of nonalcoholic steatohepatitis

Abstract

Objective We recently reported that curcumin supplementation in a metabolically (i.e., Western diet [WD]) and chemically (i.e., CCl 4 ) induced female rat model of non-alcoholic steatohepatitis (NASH) was associated with lower liver pathology scores and molecular markers of inflammation. This occurred when curcumin was given during induction of disease (preventative arm; 8-week WD with or without curcumin [8WD + C vs. 8WD]) as well as when given after disease development (treatment arm; 12-week WD with or without curcumin during weeks 9–12 [12WD + C vs. 12WD]). Herein, we sought to extend our findings from that study by determining the effects of curcumin supplementation on cytokine/chemokine expression in serum collected from these same rats. Results 24 cytokines/chemokines were assayed. IL-2 (+ 80%) and IL-13 (+ 83%) were greater with curcumin supplementation in the prevention arm. IL-2 (+ 192%), IL-13 (+ 87%), IL-17A (+ 81%) and fractalkine (+ 121%) were higher while RANTES was lower (− 22%) with curcumin supplementation in the treatment arm ( p < 0.05 for all). RANTES concentrations also correlated significantly with hepatic pathology scores of inflammation (r = 0.417, p = 0.008). Select serum cytokines/chemokines were affected with curcumin supplementation in this female rat model of NASH. Moreover, curcumin’s effect(s) on RANTES and its association with liver disease pathogenesis and progression may warrant further investigation.

Role of CD4+ T-cells in the pathology of non-alcoholic fatty liver disease and related diseases

“…Curcumin, which is known as a natural polyphenol with antioxidant and anti-inflammatory properties, has the potential as an adjunct therapy for the prevention and treatment of NAFLD [380] . Curcumin treatment increased serum IL-13 levels in WD-fed female rats [381] .…”

The role of dietary antioxidants in type 2 diabetes and neurodegenerative disorders: An assessment of the benefit profile

“…The anti-diabetic effect of curcumin possibly comes from its ability to suppress OS and the inflammatory process. It targets inflammatory pathways and modulates/normalizes inflammatory mediators (e.g., TNF–α, INF-γ), systemic inflammatory biomarkers (e.g., RANTES), and other inflammatory cytokines [ [158] , [159] , [163] ]. Curcumin regulates the expression of keap1 and restores the function of NRF2, promoting insulin sensitivity and redox homeostasis [ 158 , 160 , 161 ].…”